University of Arizona Cancer Center

Quick Facts

Organization
University of Arizona Cancer Center

Number of Trials
200+

Product(s)
eBinders

Why Florence?

How Florence helps the University of Arizona Cancer Center eliminate shadow-charts with electronic EMR capture and prepare for future technology transitions.

The only National Cancer Institute-designated Comprehensive Cancer Center headquartered in the state of Arizona. Bringing promising new therapies from the laboratory to the bedside across 200+ clinical trials.

Operationally, digital collaboration brings about so much improvement it is well worth every dollar you invest in it.

Chad Adams - Associate Director, Clinical Research, University of Arizona Cancer Center

Challenge to Solve

Eliminate shadow-charts for EMR source capture and transition to a fully electronic solution to enable remote source collection, review, and monitoring.

Florence Solutions

Florence delivered the Florence ePrinter to securely transfer source documents from the EMR to the appropriate location in Florence eBinders. This front-end integration is simple for any team member to use to capture source data for remote SDV compliantly

Key Outcomes

  • Florence ePrinter is now capturing all source data from the EMR for UACC studies.
  • Elimination of all paper shadow-charts and binder rooms.
  • Expanded capabilities to include eRegulatory and other clinical trial document processes.
  • Using Florence eBinders as a foundation for additional technology innovations.

Related Success Stories

Prostate Cancer Clinical Trial Consortium (PCCTC)

How Florence helps PCCTC standardize research operations and enable remote collaboration as a national consortium.

Read more.

Largest Oncology Research Physician Network in US

How Florence delivered significant efficiency gains across the largest oncology research physician network in the country.

Read More.

Mount Sinai Health System: Multicenter Case Study

Mount Sinai Health System chooses Florence eBinders™ to streamline multi-center trial oversight.

Read More.